Improved survival after variceal hemorrhage over an 11-year period in the Department of Veterans Affairs

American Journal of Gastroenterology

Volumn 95, Issue 12, 2000, Pages 3566-3573

  El Serag, Hashem B ^a   Everhart, James E ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASCITES; BLEEDING; COHORT ANALYSIS; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONITIS; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL RATE;

EID: 0033637225     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(00)02169-9     Document Type: Article

References (30)

1. Groszmann RJ, de Franchis R. Portal hypertension. In: Schiff ER, Sorrell MF, Maddrey WC, eds. Schiff’s diseases of the liver, 8th ed. New York: Lippincott-Raven, 1999:387–442.
2. Fleischer D. Etiology and prevalence of severe persistent upper gastrointestinal bleeding. Gastroenterology 1983;84: 538–43.
3. Pinto HC, Abrantes A, Esteves AV, et al. Long-term prognosis of patients with cirrhosis of the liver and upper gastrointestinal bleeding. Am J Gastroenterol 1989;84:1239–43. 3572 El-Serag and Everhart AJG – Vol. 95, No. 12, 2000
4. Graham DY, Smith JL. The course of patients after variceal hemorrhage. Gastroenterology 1981;80:800–9.
5. Garceau AJ, Chalmers TC. The natural history of cirrhosis: Survival with esophageal varices. N Engl J Med 1963;268: 469–73.
6. Nachlas MM, O’Neil JE, Campbell AJA. The life history of patients with cirrhosis of the liver and bleeding esophageal varices. Ann Surg 1955;141:10–23.
7. D’Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: A meta-analytic review. Hepatology 1995;22: 332–54.
8. Grace ND. Diagnosis and treatment of gastrointestinal bleeding secondary to portal hypertension. Am J Gastroenterol 1997;92:1081–91.
9. Paquet KJ, Feussner H. Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices: A prospective randomized controlled trial. Hepatology 1985;5:580–3.
10. de Franchis R. Treatment of bleeding esophageal varices: A meta-analysis. Scand J Gastroenterol 1994;24(suppl 207):29–33.
11. Veteran Affairs Cooperative Variceal Sclerotherapy Group. Sclerotherapy for male cirrhotic patients who have bled from esophageal varices: Results of a randomized, multicenter clinical trial. Hepatology 1994;20:618–25.
12. Page WF, Mahan CM, Kang HK. Vital status ascertainment through the files of the department of Veterans Affairs and the social security administration. Ann Epidemiol 1996;6:102–9.
13. World Health Organization. The international classification of diseases, 9th revision. Clinical modification. 3rd ed. DHHS Publication no. (PHS) 89-1260. Washington, DC: Public Health Service, US Government Printing Office, March 1989.
14. Boyle CA, Decoufle´ P. National sources of vital status information: Extent and coverage and possible selectivity in reporting. Am J Epidemiol 1990;131:160–8.
15. Page WF. VA mortality reporting for World War II army veterans. Am J Epidemiol 1992;82:124–5.
16. Boyko EJ, Koepsell TD, Gaziano JM, et al. US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol 2000;151:307–14.
17. SAS Institute. SAS/STAT user’s guide, version 6, 4th ed. Cary, NC: SAS Institute, 1989:1028.
18. SAS Institute. SAS/STAT Software: Changes and enhancements, release 6.10. Cary, NC: SAS Institute, 1994:85.
19. Pagliaro L, D’Amico G, Pasta L, et al. Efficacy and efficiency of treatments in portal hypertension. In: de Franchis R, ed. Portal hypertension II. Oxford: Blackwell Science, 1996:159–79.
20. McDougall BRD, Westaby D, Theodossi A, et al. Increased long-term survival in variceal hemorrhage using injection sclerotherapy. Results of a controlled trial. Lancet 1988;i:124–7.
21. Goodale RL, Silvis SE, O’leary JF, et al. Early survival after sclerotherapy for bleeding esophageal varices. Surg Gynecol Obstet 1982;155:523–8.
22. Steigmann GV, Goff JS, Sun JH, et al. Endoscopic variceal ligation: An alternative to sclerotherapy. Gastrointest Endosc 1989;35:431–4.
23. Steigmann G, Goff J, Michaletz-Onody P, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992;326:1527–32.
24. Everhart JE, Hoofnagle. Hepatitis B-related end stage liver disease. Gastroenterology 1992;103:1692–4.
25. National Center for Health Statistics. Advance report of final mortality statistics, 1989. Monthly vital statistics report. Volume 40, no. 8 (suppl 2). Hyattsville, MD: US Public Health Service, 1992.
26. Grant BF, DeBakey S, Zobeck TS. Liver cirrhosis mortality in the United States, 1973–1988. National Institute on Alcohol Abuse and Alcoholism Surveillance report no. 18. Rockville, MD: US Public Health Service, 1991.
27. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999:340;745–50.
28. Lloyd SS, Rissing JP. Physician and coding errors in patient records. JAMA 1985;254:1330–6.
29. Kashner TM. Agreement between administrative files and written medical records. A case of the Department of Veterans Affairs. Med Care 1998;36:1324–36.
30. A primer on outcomes research for the gastroenterologist: Report of the American Gastroenterological Association Task Force on Outcomes Research. Gastroenterology 1995;109:302–6.